BiomEdit
PrivateLast Round
Grant
Oct 24, 2025
Total Funding Raised
$103.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BiomEdit is a biotechnology company that develops a microbiome innovation platform to discover and create products that enhance animal protein production and improve livestock disease monitoring through microbiome-derived bioactive and engineered microbial medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiomEdit Comparables
Compare BiomEdit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hoofprint Biome | 83% | |
| ArkeaBio | 81% | |
| Native Microbials | 80% |
BiomEdit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 24, 2025 | ||||
| Grant | Jul 16, 2025 | ||||
| Series B | Jul 15, 2025 | ||||
| Grant | Nov 1, 2023 | ||||
| Series A | Feb 18, 2023 | ||||
Series A | Apr 11, 2022 |
Key People
Founding team and executive leadership
BiomEdit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevate Ventures | Series B |
| NIH RADx | Grant |
| Anterra Capital | Series A, Series B |
| Bezos Earth Fund | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Viking Global Investors | Series A |
| Global Methane Hub | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2025
Secured $2M in grant funding.
- Jul 16, 2025
$1.7M grant from Global Methane Hub, NIH RADx, and USDA.
Recent news
Latest coverage and updates
- is_developingAug 26, 2026
BiomEdit, Inc. is developing genetically engineered bacterial biologics on Jul 1st '22.
- is_developingAug 26, 2026
BiomEdit, Inc. will develop class of bio-based therapeutics to treat a variety of animal diseases on Jul 1st '27.
- invests_into_assetsAug 25, 2026
BiomEdit, Inc. invested into assets: technology and pipeline assets in Indianapolis, Indiana, United States, Northern America, Americas on Aug 25th '26.
BiomEdit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BiomEdit's valuation, stock price, and market status.
Is BiomEdit a public or private company?
BiomEdit is a private company.
What is the current stock price of BiomEdit?
BiomEdit is a private company with no public stock price. No recent secondary market data is available.
How much is BiomEdit worth (valuation)?
Valuation information for BiomEdit is not publicly available.
Can I buy BiomEdit stock?
BiomEdit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BiomEdit's last funding round?
BiomEdit's most recent funding round was Grant on October 23, 2025.
Who are the main investors in BiomEdit?
Key investors in BiomEdit include Anterra Capital.
Will BiomEdit IPO soon?
No public IPO plans have been announced for BiomEdit.
How can I track BiomEdit secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BiomEdit's secondary market activity and sign up for updates.